Spiraling Costs Threaten Gridlock

See allHide authors and affiliations

Science  10 Oct 2008:
Vol. 322, Issue 5899, pp. 210-213
DOI: 10.1126/science.322.5899.210

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The gold standard of medical science--the big randomized trial--is in danger of being priced out of reach by technical complexity, poor management, and paperwork.